Medium materiality6/10
Halozyme price target raised to $130 from $115 at H.C. Wainwright
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright raises target to $130 vs current price $110.79; upside implied; price change -0.86% since signal.
- Target above price; upside despite a small pullback
Key facts
- 01
Target: $130
- 02
Posted price: $110.79
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Mitchell Kapoor
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.